Fig. 3
From: Prognosis of resected non-small cell lung cancer with pleural plaques on intrathoracic findings
Prognosis of all included patients. A Recurrence free survival (RFS) was significantly worse in patients with pleural plaques (5-year RFS rate: 56.1%; 95% confidence interval [CI], 45.3%–66.3%) than in those without pleural plaques (70.0%; 95% CI, 65.2%–74.3%; P < 0.001). B Overall survival (OS) was significantly worse in patients with pleural plaques (5-year OS rate: 64.5%; 95% CI, 53.2%–74.4%) than in those without pleural plaques (79.3%; 95% CI, 74.7%–83.2%; P < 0.001)